Saskia Schmitt
Director, Biology Tubulis
Dr. Saskia Schmitt is Director of Biology at Tubulis, where she plays a critical role in advancing ADC discovery and development in the biology team. During her graduate training at LMU Munich and industry experience at MorphoSys, she focused on antibody-based therapies in oncology, gaining broad expertise in therapeutic biology. At Tubulis, she contributes to the development of breakthrough bioconjugation strategies, integrating novel payloads, target discovery, and innovative formats. Her work drives the advancement of next-generation ADCs and positions her at the forefront of innovation in therapeutic design and delivery.
Seminars
Wednesday 25th February 2026
Innovating ADCs with Tubutecan Technology from Bench to Bedside: Highlighting Development of TUB-040, a NaPi2b-Targeting ADC
11:30 am
- Detailing comprehensive preclinical evaluation of TUB-040 and work leading to translation into the clinic
- Explaining TUB-040 ADC design innovation across payload, conjugation and target
- Highlighting the clinical development strategy and potential therapeutic impact of TUB-040
